# ESC Guidelines for the Management of Peripheral Arterial and Aortic Diseases

## Metadata
- **Specialty**: Cardiology, Vascular Surgery
- **Organization**: European Society of Cardiology (ESC)
- **Year**: 2024
- **DOI**: [10.1093/eurheartj/ehae179](https://doi.org/10.1093/eurheartj/ehae179)
- **PMID**: [39210722](https://pubmed.ncbi.nlm.nih.gov/39210722/)
- **Source URL**: https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Peripheral-Arterial-and-Aortic-Diseases

## Scope
Comprehensive guidelines for diagnosis and management of peripheral arterial diseases (PAD) and aortic diseases, combining and updating 2017 PAD and 2014 aortic guidelines.

## Key Recommendations

### Diagnosis of Lower Extremity PAD

#### Clinical Assessment
- Symptom evaluation (claudication, rest pain)
- Pulse palpation
- Ankle-brachial index (ABI) measurement

#### ABI Interpretation
| ABI Value | Interpretation |
|-----------|----------------|
| >1.40 | Non-compressible (calcified vessels) |
| 1.00-1.40 | Normal |
| 0.91-0.99 | Borderline |
| ≤0.90 | Abnormal (PAD) |
| <0.40 | Severe PAD/CLI |

#### Additional Testing
- Toe-brachial index (TBI) if ABI non-compressible
- Duplex ultrasound
- CT angiography
- MR angiography

### Medical Management of PAD

#### Risk Factor Modification (Strong)
| Intervention | Target |
|--------------|--------|
| Smoking cessation | Complete abstinence |
| LDL-C | <55 mg/dL (<1.4 mmol/L) |
| Blood pressure | <130/80 mmHg |
| Diabetes | HbA1c <7% (individualized) |

#### Antithrombotic Therapy
- Aspirin 75-100 mg daily OR Clopidogrel 75 mg daily
- Dual antithrombotic (rivaroxaban 2.5 mg BID + aspirin) for high-risk patients
- Consider after revascularization

#### Lipid-Lowering Therapy
- High-intensity statin for all PAD patients
- Add ezetimibe if LDL-C not at goal
- Consider PCSK9 inhibitors for very high-risk

### Intermittent Claudication

#### First-Line Treatment
- Supervised exercise therapy (SET)
- Minimum 30-45 minutes, 3× weekly, 12 weeks
- Structured walking programs

#### Pharmacotherapy
- Cilostazol (if no heart failure)
- Limited evidence for other agents

#### Revascularization
- Consider if lifestyle-limiting symptoms despite SET
- Endovascular preferred for most lesions
- Surgery for complex disease or failed endovascular

### Chronic Limb-Threatening Ischemia (CLTI)

#### Definition
- Rest pain requiring analgesia for >2 weeks
- Ulceration or gangrene
- ABI <0.40 or toe pressure <30 mmHg

#### Management
- Urgent vascular assessment
- Wound care
- Pain management
- Revascularization when feasible

#### Revascularization Strategy
- Endovascular-first for most patients
- Bypass surgery for good surgical candidates with durable conduit
- Consider GLASS (Global Limb Anatomic Staging System)

### Carotid Artery Disease

#### Indications for Revascularization
| Stenosis | Symptoms | Recommendation |
|----------|----------|----------------|
| 70-99% | Symptomatic (TIA/stroke within 6 months) | CEA or CAS |
| 50-69% | Symptomatic | CEA preferred |
| 60-99% | Asymptomatic | Individualized decision |

#### CEA vs. CAS
- CEA preferred for most symptomatic patients
- CAS reasonable if high surgical risk
- Operator/center experience important

### Aortic Aneurysm

#### Abdominal Aortic Aneurysm (AAA)
| Diameter | Recommendation |
|----------|----------------|
| <55 mm (men) | Surveillance |
| <50 mm (women) | Surveillance |
| ≥55 mm (men) | Consider repair |
| ≥50 mm (women) | Consider repair |
| Rapid growth (>10 mm/year) | Consider repair |

#### Repair Options
- EVAR (endovascular) for suitable anatomy
- Open surgical repair
- Choice based on anatomy, age, comorbidities

#### Thoracic Aortic Aneurysm
- Monitor for Marfan, bicuspid aortic valve
- Surgery typically at 55 mm (50 mm for high-risk)

### Aortic Dissection

#### Type A (Ascending)
- Surgical emergency
- Immediate transfer to aortic surgery center

#### Type B (Descending)
- Medical management for uncomplicated
- Endovascular repair for complicated (malperfusion, rupture)

### Renal Artery Stenosis

#### Diagnosis
- Duplex ultrasound screening
- CTA/MRA for confirmation

#### Management
- Medical therapy (ACE-I/ARB, statin, antiplatelet)
- Revascularization rarely indicated
- Consider for refractory hypertension, flash pulmonary edema

### Mesenteric Ischemia

#### Acute Mesenteric Ischemia
- Surgical/interventional emergency
- CT angiography for diagnosis
- Revascularization + bowel assessment

#### Chronic Mesenteric Ischemia
- Postprandial pain, weight loss
- Revascularization for symptomatic disease

### Multidisciplinary Care
- Vascular medicine/surgery
- Cardiology
- Radiology
- Wound care
- Podiatry
- Rehabilitation

